Evidence map›Paper›PMID 24748324›Full record

ArticlePloS one2014

Purinergic signaling on leukocytes infiltrating the LPS-injured lung.

Daniela Friebe, Tao Yang, Timo Schmidt, Nadine Borg, Bodo Steckel, Zhaoping Ding, Jürgen Schrader

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Adenosine ACurrent issues in molecular biology · 2023
    Article
  3. Inhibition of NETosis for treatment purposes: friend or foe?Molecular and cellular biochemistry · 2022
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Role of Cardiac AFrontiers in pharmacology · 2020
    Review
  10. Article
  11. Review
  12. Purinergic Signalling: Therapeutic Developments.Frontiers in pharmacology · 2017
    Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Daniela FriebeDepartment of Molecular Cardiology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Tao YangDepartment of Molecular Cardiology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany; Department of Anesthesiology and Intensive Care Medicine, Changhai Hospital, Second Military Medical University, Shanghai, PR China.
Timo SchmidtDepartment of Molecular Cardiology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Nadine BorgDepartment of Molecular Cardiology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Bodo SteckelDepartment of Molecular Cardiology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Zhaoping DingDepartment of Molecular Cardiology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Jürgen SchraderDepartment of Molecular Cardiology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Heinrich Heine University Düsseldorf · DESecond Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular nucleotides and nucleosides have been implicated as important signaling molecules in the pathogenesis of acute lung injury (ALI). While adenosine is known to inhibit T cell activation, little information is available as to ATP and NAD degrading enzymes, the expression of ATP and adenosine receptors/transporters in different T cell subsets. ALI was induced by challenging mice with intra-tracheal instillation of 60 µl (3 µg/g) LPS. After 3 d and 7 d blood, lung tissue and bronchoalveolar lavage was collected and immune cells were analyzed using flow cytometry. The transcriptional phenotype of T helper cells, cytotoxic and regulatory T cells sorted by FACS was assessed by measuring the expression profile of 28 genes related to purinergic signaling using TaqMan Array Micro Fluidic Cards. Catabolism of ATP, NAD and cAMP by activated CD4+ T cells was evaluated by HPLC. CD73 was found to be highly abundant on lymphoid cells with little abundance on myeloid cells, while the opposite was true for CD39. After ALI, the abundance of CD39 and CD73 significantly increased on all T cell subsets derived from lung tissue and bronchoalveolar space. Expression analysis in T cell subsets of the lung revealed ATP (Cd39, Cd73) and NAD (Cd38, Cd157, Cd296, Pc-1) degrading enzymes. However, only transcription of Cd38, Cd39, Cd73, Ent1 and A2a receptor was significantly upregulated after ALI in T helper cells. CD4+ T cells from injured lung rapidly metabolized extracellular ATP to AMP and adenosine but not NAD or cAMP. These findings show that lung T cells--the dominant cell fraction in the later phase of ALI--exhibit a unique expression pattern of purinergic signaling molecules. Adenosine is formed by T cells at an enhanced rate from ATP but not from NAD and together with upregulated A2a receptor is likely to modulate the healing process after acute lung injury.

Indexed as

Signal Transduction5'-NucleotidaseAnimalsAntigens, CDApyraseChromatography, High Pressure LiquidLeukocytesLipopolysaccharidesLung InjuryMiceReal-Time Polymerase Chain ReactionReceptors, Purinergic5'-NucleotidaseAntigens, CDApyraseCD39 antigenLipopolysaccharidesReceptors, Purinergic

Identifiers

PMID24748324
PMCPMC3991673
OpenAlexW2052052286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.